Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Home-Based Physical Activity in Patients With Breast Cancer: During and/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC).

Tytuł:
Home-Based Physical Activity in Patients With Breast Cancer: During and/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC).
Autorzy:
Vincent F; Department of Physiology, University Hospital, Limoges, France.; Faculty of Medicine, University of Limoges, Limoges, France.
Deluche E; Faculty of Medicine, University of Limoges, Limoges, France.; Department of Medical Oncology, University Hospital, Limoges, France.
Bonis J; Faculty of Medicine, University of Limoges, Limoges, France.
Leobon S; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Antonini MT; Department of Physiology, University Hospital, Limoges, France.
Laval C; Department of Physiology, University Hospital, Limoges, France.; Faculty of Medicine, University of Limoges, Limoges, France.
Favard F; Department of Physiology, University Hospital, Limoges, France.
Dobbels E; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Lavau-Denes S; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Labrunie A; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Thuillier F; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Venat L; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Tubiana-Mathieu N; Faculty of Medicine, University of Limoges, Limoges, France.; Department of Medical Oncology, University Hospital, Limoges, France.; Department of Biostatistics and Clinical Research, University Hospital, Limoges, France.
Źródło:
Integrative cancer therapies [Integr Cancer Ther] 2020 Jan-Dec; Vol. 19, pp. 1534735420969818.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Thousand Oaks, CA : Sage Publications, c2002-
MeSH Terms:
Breast Neoplasms*/drug therapy
Cardiorespiratory Fitness*
Exercise ; Exercise Therapy ; Female ; Humans ; Muscle Strength ; Physical Fitness ; Quality of Life ; Treatment Outcome
References:
J Phys Act Health. 2015 Jun;12(6):823-33. (PMID: 25155470)
Soc Sci Med. 1999 Jun;48(11):1507-15. (PMID: 10400253)
Cancer. 2007 Aug 15;110(4):918-25. (PMID: 17582616)
J Clin Oncol. 2005 Apr 1;23(10):2378-88. (PMID: 15800330)
Biomed Res Int. 2017;2017:8367803. (PMID: 28835898)
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419879748. (PMID: 31561728)
Am J Prev Med. 2002 May;22(4 Suppl):73-107. (PMID: 11985936)
BMC Cancer. 2015 Feb 21;15:77. (PMID: 25885168)
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81. (PMID: 21681120)
Breast Cancer Res Treat. 2015 Jan;149(1):109-19. (PMID: 25417174)
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. (PMID: 31626055)
Eur J Cancer. 1998 Mar;34(4):510-7. (PMID: 9713301)
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26. (PMID: 20559064)
Cochrane Database Syst Rev. 2016 Sep 21;9:CD005001. (PMID: 27650122)
Eur J Cancer Care (Engl). 2011 Jan;20(1):96-105. (PMID: 20345456)
J Cancer Surviv. 2019 Apr;13(2):205-223. (PMID: 30806875)
Ann Oncol. 2013 Feb;24(2):291-300. (PMID: 23041586)
Epidemiol Rev. 2017 Jan 1;39(1):71-92. (PMID: 28453622)
Breast Cancer Res Treat. 2015 Jan;149(2):331-42. (PMID: 25555831)
Maturitas. 2016 Mar;85:104-11. (PMID: 26857888)
Med Sci Sports Exerc. 2009 Apr;41(4):742-8. (PMID: 19276861)
J Clin Oncol. 2003 May 1;21(9):1660-8. (PMID: 12721239)
Int J Cancer. 2020 Jan 1;146(1):150-160. (PMID: 31173341)
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. (PMID: 8433390)
Clin Cancer Res. 2009 Apr 15;15(8):2920-6. (PMID: 19351764)
J Lifestyle Med. 2017 Jul;7(2):55-62. (PMID: 29026725)
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. (PMID: 12091180)
Breast. 2017 Jun;33:166-177. (PMID: 28415013)
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. (PMID: 12900694)
Health Qual Life Outcomes. 2018 Apr 6;16(1):58. (PMID: 29625622)
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33. (PMID: 21051654)
Eur J Phys Rehabil Med. 2016 Apr;52(2):223-32. (PMID: 25986222)
Appl Physiol Nutr Metab. 2011 Dec;36(6):892-903. (PMID: 22067010)
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820)
J Clin Oncol. 2005 May 20;23(15):3577-87. (PMID: 15908668)
Lancet Oncol. 2008 Aug;9(8):757-65. (PMID: 18672211)
Int J Behav Med. 2013 Dec;20(4):522-8. (PMID: 22992864)
Support Care Cancer. 2016 Jan;24(1):119-127. (PMID: 25957010)
Acta Oncol. 2017 Apr;56(4):618-627. (PMID: 28084890)
Support Care Cancer. 2016 Feb;24(2):969-983. (PMID: 26482381)
Curr Cancer Rep. 2019;1(1):6-12. (PMID: 31773112)
Br J Sports Med. 2009 Jan;43(1):32-8. (PMID: 18948351)
J Clin Oncol. 2012 Jul 10;30(20):2530-7. (PMID: 22614980)
BMJ. 2012 Jan 30;344:e70. (PMID: 22294757)
Braz J Med Biol Res. 2015 Apr;48(4):349-53. (PMID: 25714888)
J Psychosom Res. 1995 Apr;39(3):315-25. (PMID: 7636775)
Cancer Nurs. 2012 Jan-Feb;35(1):48-54. (PMID: 21558852)
J Am Heart Assoc. 2014 Jan 13;3(1):e000432. (PMID: 24419734)
Int J Behav Nutr Phys Act. 2020 Feb 14;17(1):23. (PMID: 32059728)
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1588-95. (PMID: 16030088)
Med Sci Sports Exerc. 2008 Jun;40(6):1180-7. (PMID: 18460985)
Appl Physiol Nutr Metab. 2007;32 Suppl 2F:S75-S171. (PMID: 19377547)
Psychooncology. 2009 Apr;18(4):422-8. (PMID: 19243089)
J Clin Oncol. 2007 Oct 1;25(28):4396-404. (PMID: 17785708)
J Cancer Surviv. 2012 Dec;6(4):420-30. (PMID: 22836201)
J Cancer Surviv. 2010 Jun;4(2):87-100. (PMID: 20052559)
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7. (PMID: 9817683)
Oncol Nurs Forum. 2014 Sep;41(5):461-9. (PMID: 25158652)
Cancer Treat Rev. 2017 Jan;52:91-104. (PMID: 28006694)
BMJ. 2007 Mar 10;334(7592):517. (PMID: 17307761)
Integr Cancer Ther. 2018 Mar;17(1):16-30. (PMID: 28008778)
Ann Oncol. 2016 Jun;27(6):965-974. (PMID: 26940687)
Am J Public Health. 1998 Dec;88(12):1807-13. (PMID: 9842378)
Contributed Indexing:
Keywords: adapted physical activity; breast cancer; chemotherapy; home training; peak oxygen consumption
Molecular Sequence:
ClinicalTrials.gov NCT01795612
Entry Date(s):
Date Created: 20201124 Date Completed: 20210818 Latest Revision: 20210818
Update Code:
20240105
PubMed Central ID:
PMC7691904
DOI:
10.1177/1534735420969818
PMID:
33228382
Czasopismo naukowe
Objectives: Physical activity (PA) programs are recommended for breast cancer care. However, their modalities remain to be discussed. This study determined the best time to begin a personalized or adapted program based on cardiopulmonary exercise test function. This randomized controlled trial evaluated the effect of home-based adapted PA (APA) performed during or after treatment on cardiorespiratory fitness (CRF) at 12 months.
Method: The primary endpoint was the peak oxygen consumption (VO 2peak ) at 12 months (group A vs C and B vs C). Secondary endpoints included the 6-minute walking test, assessment of muscle strength, fatigue, quality of life, anxiety, and depression, and a questionnaire on PA levels. All tests were evaluated at baseline and at 6 and 12 months. A total of 94 patients with breast cancer were randomized to 3 different groups: group A, performing 6 months of APA during adjuvant care; group B, 6 months of APA after adjuvant care; and group C, 12 months of APA during and after specific care. The program combined 1 resistance session and 2 aerobic sessions per week. Analysis of variance was used for repeated measures, Student's t -test or the Mann-Whitney U -test for continuous variables, and χ 2 test for binary or categorical variables.
Results: The study assessed 81 participants at 6 months and 73 at 12 months. The majority of patients completed more than 85% of the exercise sessions. The baseline for VO 2peak and secondary outcomes did not differ among the groups. VO 2peak increased during the exercise period and decreased during the chemotherapy period without APA, but at 12 months no significant difference was observed. The same variation was observed in the 6-minute walking test, with significance at 6 months between A+C versus B ( P  = .04), but no difference among the groups at 12 months. In the 3 groups, no decreases in other studied parameters were noted, except at 6 months in group B without APA.
Conclusion: Home-based APA in breast cancer patients has a positive effect on CRF and physical functions, with no differences based on the timing of this program based on specific cancer treatment.
Trial Registration: ClinicalTrials.gouv.fr (NCT01795612). Registered 20 February 2013.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies